Cost-effectiveness analysis of pharmaceutical-grade chondroitin sulfate in the treatment of knee osteoarthritis: a post hoc assessment derived from individual patient data from a randomised clinical triall

Bruyère, Olivier; Reginster, Jean-Yves

Paper published in a journal (Scientific congresses and symposiums)

Bruyère, Olivier; Reginster, Jean-Yves

2024 • In Aging Clinical and Experimental Research

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/318215

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

P1009 - Cost-effectiveness analysis ... Abstract Book p604.pdf

Publisher postprint (71.26 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Public health, health care sciences & services

Author, co-author :

Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé

Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique

Language :

English

Title :

Publication date :

2024

Event name :

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

Event organizer :

WCO-IOF-ESCEO

Event place :

London, United Kingdom

Event date :

11 avril -14 avril 2024

Audience :

International

Journal title :

Aging Clinical and Experimental Research

ISSN :

1594-0667

eISSN :

1720-8319

Publisher :

Springer, Germany

Special issue title :

and Abstract Book of the Congress

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 16 May 2024

Statistics

Number of views

19 (5 by ULiège)

Number of downloads

33 (4 by ULiège)

More statistics